Tag:

drug delivery patent

Latest Headlines

Latest Headlines

USPTO to review delivery patent in spat between Suboxone and BDSI's Bunavail

MonoSol Rx announced that the U.S. Patent and Trademark Office will decide by August 2015 whether BioDelivery Sciences International's BEMA drug delivery technology infringes on a patent protecting its Suboxone sublingual film.

Patent cliff could create need for novel delivery tech

As blockbusters go off patent and generics companies scramble to compete, novel drug delivery tech could be the difference-maker in the marketplace.

Tekmira seeks court's rejection of Alnylam drug delivery patent suit

Tekmira Pharmaceuticals ($TKMR) fired back at Alnylam Pharmaceuticals ($ALNY) in federal court this week, with an attempt to get rid of the Massachusetts company's patent lawsuit over siRNA and lipid nanoparticle drug delivery technology.

UPDATED: Alnylam throws legal punch in patent fight with RNAi tech partner Tekmira

This is growing nastier. Alnylam Pharmaceuticals ($ALNY) has fired the latest round—this time in federal court—in an ongoing patent feud with development partner Tekmira Pharmaceuticals (...

Endo grabs BDSI's drug film chronic pain treatment through global license

BioDelivery Sciences International ($BDSI)'s dissolvable drug delivery film to treat chronic pain from inside the cheek is still under development and endured a recent clinical setback. But it's

Drug-delivery devices could run on power from the body

It's the stuff of science fiction: Batteries running on natural energy sources in the body. Yet developers of so-called "bio fuel cells" have advanced their prototypes into small-animal testing, and

Lincoln Pharma gets patent for nasal delivery of anti-vomiting drug

There are many reasons cancer patients can dread chemotherapy. It might kill their cancer, but those who go through it often wonder if the cure is just as bad as the disease. Among the uncomfortable

Court rules in IntelGenx's favor in Wellbutrin-maker's lawsuit

Quebec-based IntelGenx received a positive ruling Tuesday in a case involving two patents owned by Biovail Laboratories, the maker of the antidepressant Wellbutrin XL. The U.S. District Court of

Chinese company gets patent on diabetes controlled release

Lotus Pharmaceuticals, a Chinese drug developer, announced that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the

Encap Drug Delivery awarded patents for DuoCap

Encap Drug Delivery, based in the UK, has been awarded European and US patents for the company's DuoCap capsule delivery system. DuoCap is just what it sounds like, a capsule-within-a-capsule, or a